Solta Medical
Solta Medical, a Bausch Health subsidiary, designs and markets energy-based aesthetic medical devices — including Thermage FLX, Clear + Brilliant, Fraxel, and VASERlipo — sold directly to physicians, dermatologists, and medspas across the US, Canada, and China.
- Company typePrivate
- Founded1995
- HeadquartersHayward, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Solta Medical does
Solta Medical, a wholly-owned subsidiary of Bausch Health Companies Inc. (NYSE: BHC), designs, develops, and markets energy-based medical device systems for aesthetic applications. Founded in 1995 and headquartered in Bothell, Washington with 251-500 employees, the company sells a portfolio of FDA-cleared, Health Canada-approved, and NMPA-approved devices: Thermage FLX (monopolar radiofrequency skin tightening, the only non-invasive technology indicated for upper and lower eyelids), Clear + Brilliant Touch (dual-wavelength non-ablative fractional laser), Fraxel FTX (1550nm/1927nm fractional laser), VASERlipo (ultrasonic body contouring), and the UltraCel Q+ multi-technology platform. The Thermage brand has surpassed 5 million cumulative treatments globally and received AAA Well-Known Trademark Certification in China in 2026.
Solta generates revenue primarily through direct capital equipment sales to physicians, dermatologists, cosmetic surgeons, medical spas, and aesthetic clinics, with international markets historically served through channel partners. In December 2025, the company acquired its longtime Chinese distributor (Wuhan Shibo Zhenmei Technology) to directly control its China distribution network — a market where Thermage contributed 33% of brand revenue in 2022. The go-to-market combines enterprise field sales, a consumer-facing "Find a Provider" referral tool, dedicated brand-specific product websites, and national PR-driven marketing such as the October 2025 feature on Lifetime's The Balancing Act. Geographic coverage spans the United States, Canada (entry February 2026), and China, with a global footprint claim across additional markets.
Solta Medical firmographics
Firmographics- Name
- Solta Medical
- Legal name
- Solta Medical Inc.
- Website
- https://solta.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Solta Medical, a Bausch Health subsidiary, designs and markets energy-based aesthetic medical devices — including Thermage FLX, Clear + Brilliant, Fraxel, and VASERlipo — sold directly to physicians, dermatologists, and medspas across the US, Canada, and China.
- Ownership category
- akta.pro rank
Solta Medical industry classification
Industry- Product category
- Aesthetic Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Laser & Energy-Based Dermatology (HLAKACAF)
- akta.pro secondary industry
- Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices) (CRABAAAJ)
Keywords
Where Solta Medical is headquartered
LocationHeadquarters
- HQ city
- Hayward
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Solta Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Solta Medical generates revenue through the sale of aesthetic medical devices to physicians, dermatologists, and medical practices. The company sells equipment outright to practitioners who then use them to perform treatments on patients.
- Thermage Brand Revenue (China): China operations contributed 33% of Thermage's revenue in 2022, demonstrating significant international revenue streams from aesthetic device treatments and related operations in the Asia-Pacific region.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
Solta Medical product offering
Product offeringCore offering
Solta Medical designs, develops, and markets energy-based medical device systems for aesthetic applications. Its product portfolio includes the Thermage FLX monopolar radiofrequency skin tightening system, Clear + Brilliant Touch dual-wavelength fractional laser, Fraxel FTX 1550nm/1927nm fractional laser systems, VASERlipo ultrasonic body contouring system, and UltraCel Q+ multi-technology platform. These devices are sold to physicians, dermatologists, and medical practices to deliver non-invasive skin rejuvenation, skin tightening, wrinkle reduction, and body contouring treatments.
Product overview
Solta Medical, a division of Bausch Health, offers a portfolio of energy-based aesthetic medical devices including Thermage FLX (monopolar radiofrequency skin tightening), Clear + Brilliant Touch (dual-wavelength fractional laser), Fraxel FTX (1550nm/1927nm laser systems), and VASERlipo (ultrasonic liposuction system). The company also offers UltraCel Q+ platform. These devices target non-invasive skin rejuvenation, body contouring, and surgical aesthetic procedures across dermatology and plastic surgery applications.
Differentiator
Problem solved
Functional benefit
Brands
- Thermage: Radiofrequency skin tightening system for non-invasive treatment of wrinkles and skin laxity
- Clear + Brilliant
- Fraxel
- VASERlipo
Products and services
- Thermage FLX
- Clear + Brilliant Touch Dual-wavelength non-ablative fractional laser system for non-invasive skin rejuvenation that improves skin tone, texture, fine lines, pore size, and overall skin appearance. Suitable for all skin types. Sold to physicians and aesthetic practices.
- Fraxel FTX Fractional laser system offering 1550nm and 1927nm wavelengths for skin resurfacing, treatment of dyschromia, actinic keratosis, melasma, wrinkles around eyes, acne scars, surgical scars, and pigmented lesions. Sold to physicians and dermatologists.
- VASERlipo System Ultrasonic liposuction system for aesthetic body contouring and soft tissue removal across multiple surgical specialties including plastic and reconstructive surgery, dermatologic procedures, and general surgical applications. Sold to plastic surgeons and surgical practices.
- UltraCel Q+ Multi-technology aesthetic platform combining radiofrequency, microneedling, and other energy-based treatments for skin tightening and contouring. Sold to physicians and aesthetic practices.
Quantifiable outcome
- Over 5 million Thermage treatments performed worldwide
- +1 more outcomes
Companies that use Solta Medical
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Solta Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Solta Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Wuhan Shibo Zhenmei Technology Co., Ltd.coreSolta Medical acquired its longtime Chinese distribution partner Wuhan Shibo Zhenmei Technology (also referred to as Shibo Group) effective December 1, 2025, becoming its sole owner and fully controlling its China operations. The acquisition enables Solta Medical to directly manage its distribution network and address increasing demand for aesthetic treatments in China, where the Thermage brand has been present for over a decade and contributed 33% of Thermage's revenue in 2022.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Solta Medical competitors and assessment
Company assessmentDirect peers
- BTL Aesthetics: BTL Aesthetics markets non-invasive body contouring and skin treatment devices (EMSCULPT, EMSELLA, EMFACE) used by medspas and physicians, directly overlapping with Solta's VASERlipo and Thermage categories in the same customer base.
- Lumenis (Boston Scientific): Lumenis is a long-standing energy-based device maker (laser, IPL, RF) serving the same dermatology, plastic surgery, and medspa channels. Acquired by Boston Scientific, it competes with Solta's laser and RF platforms including Fraxel and Clear + Brilliant.
- InMode Ltd. InMode is a fast-growing energy-based aesthetic device company whose RF, laser, and body contouring platforms (Morpheus8, Evolve, BodyTite) compete head-to-head with Solta's Thermage and body contouring offerings in dermatology and plastic surgery practices.
- Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie company, is explicitly co-identified with Solta as a top-2 player in anti-aging/aesthetic devices. Its portfolio (CoolSculpting, SkinMedica, Botox) overlaps Solta's energy-based device franchise across the same physician and medspa customer base.
- Cutera Inc. Cutera develops and markets laser and energy-based aesthetic systems (e.g., AviClear, ExcelV) for dermatologists and aesthetic practices, directly competing with Solta's laser and skin rejuvenation portfolio.
- Candela Corporation: Candela manufactures energy-based aesthetic and medical laser systems used by dermatologists and plastic surgeons. Its portfolio competes with Solta's Fraxel fractional laser and other resurfacing devices in similar clinical and medspa settings.
- Alma Lasers: Alma Lasers produces RF, laser, ultrasound, and body contouring aesthetic devices for physicians and medspas, directly competing with Solta's Thermage, Clear + Brilliant, and VASERlipo platforms across overlapping indications.
- Cynosure Lutronic: Cynosure Lutronic manufactures energy-based aesthetic devices including fractional lasers, RF platforms, and body contouring systems sold to dermatologists and medspas, directly overlapping Solta's Thermage, Fraxel, and VASERlipo categories.
Emerging players
- Venus Concept Inc. Venus Concept markets energy-based aesthetic devices (RF, IPL, body contouring) primarily to medspas and aesthetic practices, partially overlapping Solta's portfolio with focus on more entry-level and consumable-driven economics.
- Sciton Inc. Sciton produces laser and light-based aesthetic and medical platforms (HALO, BBL, MOXI) sold to dermatologists and plastic surgeons, with meaningful overlap to Solta's Fraxel and Clear + Brilliant resurfacing technologies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Solta Medical social profiles
Digital presenceSolta Medical compliance and trust
Trust signalCompliance1 record
Solta Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Solta Medical leadership team
Management profileNumber of profiles
Profiles5 records
Solta Medical subsidiaries and ownership
Company hierarchySubsidiaries1 record
Solta Medical funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Solta Medical M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Solta Medical
What does Solta Medical do?
Solta Medical designs, develops, and markets energy-based medical device systems for aesthetic applications. Its product portfolio includes the Thermage FLX monopolar radiofrequency skin tightening system, Clear + Brilliant Touch dual-wavelength fractional laser, Fraxel FTX 1550nm/1927nm fractional laser systems, VASERlipo ultrasonic body contouring system, and UltraCel Q+ multi-technology platform. These devices are sold to physicians, dermatologists, and medical practices to deliver non-invasive skin rejuvenation, skin tightening, wrinkle reduction, and body contouring treatments.
Is Solta Medical a public or private company?
Solta Medical is a private company. It is classified as corporate owned and is currently operating.
When was Solta Medical founded?
Solta Medical was founded in 1995. It employs 251 to 500 people.
Where is Solta Medical based?
Solta Medical is headquartered in Hayward, United States, in the North America region.
How does Solta Medical make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are thermage Brand Revenue (China).
Who are Solta Medical's main competitors?
Direct peers on record are BTL Aesthetics, Lumenis (Boston Scientific), InMode Ltd., Allergan Aesthetics (AbbVie), Cutera Inc., Candela Corporation, Alma Lasers and Cynosure Lutronic. Emerging players are Venus Concept Inc. and Sciton Inc..
Does Solta Medical have an API?
No public API is recorded for Solta Medical.
What industry is Solta Medical in?
Solta Medical's product category is Aesthetic Medical Devices. Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology, with a secondary code of CRABAAAJ, Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices). Its NAICS code is 334510 and its SIC code is 3845.